BioSpace News Archive

Approximately 9,000 employees participate in volunteer activities to update schools and community centers all over the world benefitting more than 70,000 students and 50,000 community members

Evotec SE announced that the company has entered into a five-year partnership with the Bill & Melinda Gates Foundation to discover new treatment regimens that better address tuberculosis (“TB”), a severe global health burden and one of the leading causes of death due to infectious diseases worldwide.

Government agencies in the United States and U.K. are scrutinizing Roche’s planned acquisition of the gene therapy company.

A Phase III trial compared Sanofi’s Soliqua/Suliqua to other GLP-1 receptor agonists (GLP-1 RA), with Soliqua showing a superior decrease of average blood sugar level (HbA1c) after 26 weeks.

Under the terms of the deal, a Merck subsidiary is buying all outstanding shares of Tilos for a total of up to $773 million, including an upfront payment and various potential milestone payments.

The bankruptcy announcement comes weeks after Insys founder John Kapoor and four former executives were found guilty of orchestrating a kickback scheme to boost sales of its powerful opioid Subsys.

Trial data showed a two-week course delayed the onset of diabetes by as much as two years in clinical patients.

Medtronic plc, the global leader in medical technology, announced the enrollment of the first study participants in the company’s pivotal trial of its Bluetooth® enabled MiniMed 780G advanced hybrid closed loop system.

Medtronic plc, the global leader in medical technology, announced that it has initiated the company’s pivotal trial for its next-generation Guardian continuous glucose monitoring sensor designed to improve accuracy and overall system performance, reduce sensor calibrations and enhance overall user experience.

Multi-center 1,955 patient study published in the Journal of Urology